MANREMYC is a “spin off” of the Institut for Biomedical Research Germans Trias i Pujol (IGTP) with the mission to eradicate tuberculosis (TB) by reducing its risk of development with a unique and revolutionary product, Nyaditum resae® (NR) based on the most updated technology and a solid scientific background.